GPT and metabolic dysfunction-associated steatotic liver disease: Since the measurements of ultrasonography-diagnosed NAFLD, ALT, AST, GGT, and ALP are well standardized and available in routine clinical practice, these markers can be included in future diabetes prediction algorithms.